1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
Cellectis - ADR
XNAS: CLLS

Cellectis (ADR) Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...

Read More
3.80 -0.15 (-3.80%)
30.66% Fall from 52W High
7,772.1
XNAS Volume

XNAS 07 May, 2026 2:02 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Cellectis (ADR) is on 12 May 2026 for the purpose of Cellectis SA First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
15.2 / 100
Momentum Score
Technically Neutral
50.2 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
7
1Yr Price target upside is 91%
4 analysts

9

S

12

W

1

O

3

T

SWOT Analysis

Cellectis (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..